iShares Nasdaq US Biotechnology
(BTEK)
£4.78
Previous business day’s close price
‑£0.21 (‑4.19%)
max available period
£3.91
£5.65
04 Jan 21
26 Apr 24
Details
This ETF tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease, via the Nasdaq Biotechnology index. This ETF reinvests income.
Ticker: BTEK
ISIN: IE00BYXG2H39
Ticker: BTEK
ISIN: IE00BYXG2H39
Key information
ETF Breakdown
AMGEN Inc.
8.4%
Gilead Sciences, Inc.
8.2%
Regeneron Pharmaceuticals, Inc.
8.1%
Vertex Pharmaceuticals, Inc.
8.0%
Moderna Inc
4.2%
Astrazeneca plc
4.1%
Biogen Inc
3.2%
Illumina Inc
2.3%
Alnylam Pharmaceuticals Inc
1.9%
Biomarin Pharmaceutical Inc.
1.7%
Viatris Inc
1.5%
Neurocrine Biosciences, Inc.
1.4%
Royalty Pharma plc
1.4%
Sanofi
1.4%
Incyte Corp.
1.3%
Medpace Holdings Inc
1.3%
argenx SE
1.3%
Sarepta Therapeutics Inc
1.3%
United Therapeutics Corp
1.1%
BioNTech SE
0.9%
Ascendis Pharma A/S
0.9%
Myovant Sciences Ltd
0.9%
Jazz Pharmaceuticals plc
0.8%
Vaxcyte Inc
0.8%
Cytokinetics Inc
0.8%
Exelixis Inc
0.7%
Apellis Pharmaceuticals Inc
0.7%
Intra‑Cellular Therapies Inc
0.7%
BeiGene Ltd
0.7%
Ionis Pharmaceuticals Inc
0.7%
Blueprint Medicines Corp
0.6%
BridgeBio Pharma Inc
0.6%
CRISPR Therapeutics AG
0.6%
Canticle Pharmaceuticals Inc
0.6%
Revolution Medicines Inc
0.6%
Halozyme Therapeutics Inc.
0.5%
Krystal Biotech Inc
0.5%
Immunovant Inc
0.5%
Alkermes plc
0.5%
Legend Biotech Corp
0.5%
Nuvalent Inc
0.5%
Lion Biotechnologies Inc
0.4%
Insmed Inc
0.4%
Ultragenyx Pharmaceutical Inc.
0.4%
Axsome Therapeutics Inc
0.4%
Arcellx Inc
0.4%
Arrowhead Pharmaceuticals Inc.
0.4%
ImmunityBio Inc
0.4%
SpringWorks Therapeutics Inc
0.4%
Amicus Therapeutics Inc
0.4%
Crinetics Pharmaceuticals Inc
0.3%
Ideaya Biosciences Inc
0.3%
Xenon Pharmaceuticals Inc
0.3%
Acadia Pharmaceuticals Inc
0.3%
Denali Therapeutics Inc
0.3%
Summit Therapeutics Inc
0.3%
Arvinas Operations Inc
0.3%
Beam Therapeutics Inc
0.3%
Fortrea Holdings Inc
0.3%
Alpine Immune Sciences Inc
0.3%
Intellia Therapeutics Inc
0.3%
Merus N.V
0.3%
Rhythm Pharmaceuticals Inc.
0.3%
Apogee Therapeutics Ord Shs
0.3%
Guardant Health Inc
0.3%
Vericel Corp
0.3%
Keros Therapeutics Inc
0.3%
Kymera Therapeutics Inc
0.3%
Rocket Pharmaceuticals Inc
0.3%
Dyne Therapeutics Inc
0.2%
Immunocore Holdings plc
0.2%
PTC Therapeutics Inc
0.2%
Recursion Pharmaceuticals Inc
0.2%
Sana Biotechnology Inc
0.2%
Vera Therapeutics Inc
0.2%
Amphastar Pharmaceuticals Inc
0.2%
Structure Therapeutics Adr Inc
0.2%
Avidity Biosciences Inc
0.2%
Syndax Pharmaceuticals Inc
0.2%
Harmony Biosciences Holdings Inc
0.2%
Myriad Genetics, Inc.
0.2%
Twist Bioscience Corp
0.2%
Supernus Pharmaceuticals Inc
0.2%
Ardelyx Inc
0.2%
Edgewise Therapeutics Inc
0.2%
Geron Corp.
0.2%
Morphic Holding Inc
0.2%
Agios Pharmaceuticals Inc
0.2%
Dynavax Technologies Corp.
0.2%
Inhibrx Inc
0.2%
Kura Oncology Inc
0.2%
NovoCure Ltd
0.2%
Protagonist Therapeutics Inc
0.2%
Veracyte Inc
0.2%
4D Molecular Therapeutics Inc
0.2%
Adma Biologics Inc
0.2%
Disc Medicine Inc Ord
0.2%
Fusion Pharmaceuticals Inc
0.2%
Akero Therapeutics Inc
0.1%
Avadel Pharmaceuticals plc
0.1%
Day One Biopharmaceuticals Inc
0.1%
AbCellera Biologics Inc
0.1%
Ironwood Pharmaceuticals Inc
0.1%
Pacira BioSciences Inc
0.1%
Vir Biotechnology Inc
0.1%
Xencor Inc
0.1%
Collegium Pharmaceutical Inc
0.1%
Deciphera Pharmaceuticals Inc
0.1%
Genmab
0.1%
Ligand Pharmaceuticals, Inc.
0.1%
Mannkind Corp
0.1%
Prothena Corporation plc
0.1%
Scholar Rock Holding Corp
0.1%
Tarsus Pharmaceuticals Inc
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Mirum Pharmaceuticals Inc
0.1%
Sage Therapeutics Inc
0.1%
89bio Inc
0.1%
Biocryst Pharmaceuticals Inc.
0.1%
EyePoint Pharmaceuticals Inc
0.1%
Pacific Biosciences of California Inc
0.1%
Relay Therapeutics Inc
0.1%
Verona Pharma Plc
0.1%
Verve Therapeutics Inc
0.1%
Zentalis Pharmaceuticals Inc
0.1%
Arcutis Biotherapeutics Inc
0.1%
Blk Ics Usd Liq Agency Dis
0.1%
Innoviva Inc
0.1%
Ocular Therapeutix Inc
0.1%
Pliant Therapeutics Inc
0.1%
Regenxbio Inc
0.1%
Silverback Therapeutics Inc
0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
Autolus Therapeutics Adr Plc
< 0.1%
Bicycle Therapeutics Plc
< 0.1%
Macrogenics Inc
< 0.1%
ORIC Pharmaceuticals Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Cullinan Oncology Inc
< 0.1%
Evolus Inc
< 0.1%
Grifols SA
< 0.1%
Kiniksa Pharmaceuticals Ltd
< 0.1%
Nurix Therapeutics Inc
< 0.1%
Prime Medicine Ord Shs
< 0.1%
Tango Therapeutics Inc
< 0.1%
Zai Lab Limited
< 0.1%
ANI Pharmaceuticals Inc
< 0.1%
Acelyrin Inc.
< 0.1%
Cabaletta Bio Inc
< 0.1%
Castle Biosciences Inc
< 0.1%
Centessa Pharmaceuticals plc
< 0.1%
Cogent Biosciences Inc
< 0.1%
CureVac N.V.
< 0.1%
Enliven Therapeutics Inc Ord
< 0.1%
Novavax, Inc.
< 0.1%
Omniab Inc
< 0.1%
SIGA Technologies Inc
< 0.1%
Savara Inc
< 0.1%
Wave Life Sciences Ltd.
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Zymeworks Inc
< 0.1%
Alector Inc
< 0.1%
Alx Oncology Holdings Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Biomea Fusion Inc
< 0.1%
Editas Medicine Inc
< 0.1%
Fulcrum Therapeutics Inc
< 0.1%
Galapagos NV
< 0.1%
HUTCHMED (China) Limited
< 0.1%
Lexicon Pharmaceuticals Inc
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Olema Pharmaceuticals Inc
< 0.1%
PetIQ Inc
< 0.1%
Phathom Pharmaceuticals Inc
< 0.1%
Tourmaline Bio Inc
< 0.1%
Travere Therapeutics Inc
< 0.1%
Adaptive Biotechnologies Corp
< 0.1%
Caribou Biosciences Inc
< 0.1%
Harrow Health Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
KalVista Pharmaceuticals Inc
< 0.1%
Marinus Pharmaceuticals Inc
< 0.1%
MaxCyte Inc
< 0.1%
Mineralys Therapeutics Ord
< 0.1%
Replimune Group Inc
< 0.1%
Revance Therapeutics Inc
< 0.1%
Taysha Gene Therapies Inc
< 0.1%
Terns Pharmaceuticals Inc
< 0.1%
Theravance Biopharma Inc
< 0.1%
UroGen Pharma Ltd
< 0.1%
Voyager Therapeutics Inc
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Anavex Life Sciences Corporation
< 0.1%
Arbutus Biopharma Corp
< 0.1%
MeiraGTx Holdings plc
< 0.1%
Nautilus Biotechnology Inc
< 0.1%
Precigen Inc
< 0.1%
Third Harmonic Bio Ord Shs
< 0.1%
Ac Immune Sa
< 0.1%
Amarin Corp
< 0.1%
Atea Pharmaceuticals Inc
< 0.1%
Coherus Biosciences Inc
< 0.1%
Erasca Inc
< 0.1%
Exscientia Plc
< 0.1%
Humacyte Inc
< 0.1%
Phibro Animal Health Corp.
< 0.1%
RAPT Therapeutics Inc
< 0.1%
Ventyx Biosciences Inc
< 0.1%
Xeris Biopharma Holdings Inc
< 0.1%
23Andme Holding Class A
< 0.1%
Amylyx Pharmaceuticals Inc
< 0.1%
Bluebird bio Inc
< 0.1%
Ovid Therapeutics Inc
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
uniQure N.V.
< 0.1%
Aclaris Therapeutics Inc
< 0.1%
Reneo Pharmaceuticals Inc
< 0.1%
Others
0.3%
No holdings found.
Please try a different search.
Please try a different search.
North America
81.4%
Europe ex‑UK
6.1%
UK
4.5%
Asia ex‑Japan
0.1%
Emerging Markets
< 0.1%
Rest of the World
7.5%
Healthcare
57.0%
Industrial
20.4%
Technology
8.4%
Consumer
0.1%
Sector ‐ Other
13.7%
Why InvestEngine
Unbeatable value
Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Choice of 620+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
